The role of biosimilar manufacturers in improving access to insulin globally
ContributorsPerrin, Christophe; Ewen, Margaret; Beran, David Henri
Published inThe Lancet Diabetes & Endocrinology, vol. 5, no. 8, 578
Publication date2017
Keywords
- Biosimilar Pharmaceuticals/economics
- Drug Industry/economics
- Global Health/economics
- Health Services Accessibility/economics
- Humans
- Hypoglycemic Agents/economics
- Hypoglycemic Agents/therapeutic use
- Insulin/economics
- Insulin/therapeutic use
Affiliation entities
Citation (ISO format)
PERRIN, Christophe, EWEN, Margaret, BERAN, David Henri. The role of biosimilar manufacturers in improving access to insulin globally. In: The Lancet Diabetes & Endocrinology, 2017, vol. 5, n° 8, p. 578. doi: 10.1016/S2213-8587(17)30218-8
Main files (1)
Article (Published version)
Identifiers
- PID : unige:144263
- DOI : 10.1016/S2213-8587(17)30218-8
- PMID : 28629907
Additional URL for this publicationhttps://linkinghub.elsevier.com/retrieve/pii/S2213858717302188
Journal ISSN2213-8587
